Indian Journal of Animal Research

  • Chief EditorK.M.L. Pathak

  • Print ISSN 0367-6722

  • Online ISSN 0976-0555

  • NAAS Rating 6.50

  • SJR 0.263

  • Impact Factor 0.4 (2024)

Frequency :
Monthly (January, February, March, April, May, June, July, August, September, October, November and December)
Indexing Services :
Science Citation Index Expanded, BIOSIS Preview, ISI Citation Index, Biological Abstracts, Scopus, AGRICOLA, Google Scholar, CrossRef, CAB Abstracting Journals, Chemical Abstracts, Indian Science Abstracts, EBSCO Indexing Services, Index Copernicus

Presence of Enterococci in Cats with Urinary Tract Infections and Antibiotic Resistance Profiles

P. Orujov1, B. Celik1, A.I. Kekec1, B. Diren Sigirci1,*
1Department of Microbiology, Istanbul University-Cerrahpasa, Faculty of Veterinary Medicine, Istanbul-34500, Türkiye.

Background: Bacterial urinary tract infection (UTI) is one of the most common diseases in cats caused by an imbalance between the natural host defence mechanisms of the urinary tract and virulent bacteria. This study investigated the prevalence and antimicrobial susceptibility of enterococci isolated from cats presenting urinary tract problems to veterinary clinics in Istanbul.

Methods: 100 urine samples were collected from cats by cystocentesis and plated on blood agar. Isolates found catalase and oxidase negative plated on Enterococcocel agar. After incubation, the isolates formed black colonies were tested by PCR using E. faecium and E. faecalis-specific primers. Then the antibiotic susceptibility of the isolates was determined.

Result: Eight of the 100 isolates that formed black colonies on Enterococcosel agar were identified as Enterococcus spp. After PCR tests, six isolates were classified as E. faecalis, one isolate was classified as E. faecium and one isolate that did not form a band was classified as Enterococcus spp. As a result of the Kirby-Bauer disc diffusion method used to determine the antibiotic susceptibility of the isolates, most resistance was found to cephalothin (100%) and penicillin, erythromycin, clindamycin and tetracycline (87.5%). While vancomycin resistance was not observed in any isolate, the lowest resistance was to enrofloxacin and ciprofloxacin (33.3%). Multiple antibiotic resistance was observed in all (100%) isolates. The presence of multi-resistant enterococci in cats represents a significant health threat. Bacterial identification and antimicrobial susceptibility testing should always be performed in urinary tract infections to guide definitive diagnosis and treatment.

Enterococci are widely distributed in nature in soil, water, plants, birds, insects and mammals. They are also part of the gastrointestinal and genital tract microbiota of many animals and humans. Although generally harmless, they are important opportunistic pathogens for humans and animals. Enterococci can cause many infections, including urinary tract infections (UTI), urogenital infections, endocarditis, meningitis, mastitis and intra-abdominal and wound infections. The two most common species isolated from clinical samples are Enterococcus faecium and Enterococcus faecalis (Kırkan et al., 2019).
       
Urinary tract infection (UTI) occurs when bacteria colonise normally sterile parts of the urinary tract. It most commonly affects the bladder. Bacterial colonisation can be superficial on the mucosa or deeper in the mucosa/submucosa (Parmar et al., 2021b). Bacterial UTI is much less commonly diagnosed in cats than in dogs and is estimated to affect 1–3% of cats during their lifetime (Chew et al., 2014; Parmar et al., 2021a). Although the disease can occur at any age, it is more common in middle-aged (2-6 years), overweight, diabetic and inactive cats. Most UTIs are caused by bacteria, usually from pathogens in the host’s enteric or distal urogenital flora. As in humans and dogs, the most common bacterial pathogen isolated from feline UTI is E. coli. However, due to the high resistance of enterococci to antimicrobial drugs, their prevalence in chronic UTI or recurrent infections is much higher than that of other bacteria (Dorsch et al., 2019; Banik et al., 2016).
       
Although enterococci are part of the microbiota of animals and humans, their ability to become multidrug resistant makes them a potential health threat. Studies have reported the transmission of pathogenic and/or antimicrobial-resistant bacteria from pets to their owners. Therefore, the surveillance of drug-resistant pathogens in pets living with us at home is crucial for public health and veterinary medicine. While enterococci attract attention with their natural resistance to many antibiotics, such as penicillin, cephalosporin, quinolone and aminoglycosides used in the treatment of infections caused by Gram-positive organisms, it has also been found that they can generate new antibiotic resistance and can transfer this resistance via plasmids (Tumpa et al., 2022; Kataoka et al., 2014; Dotto et al., 2018).
       
The aim of this study was to isolate, identify and highlight the importance of Enterococcus species in domestic cats. At the same time, it aimed to reveal antibiotic resistance profiles by performing antimicrobial susceptibility tests.
Between April and August 2023, 100 cats with urinary tract problems were brought to private practices and Istanbul University-Cerrahpaşa Veterinary Faculty Hospital for urine samples taken by cystocentesis. The sex, age, breed and neuter status of the cats were recorded. Thirty-one cats are female, 69 are male, five are less than one year old, 63 are between 1-7 years old, 26 are older than seven years and six are unknown. Looking at the breeds of the cats, 79 were defined as Mixed, eight were defined as British Shorthair, six were Scottish, three were Siamese, two were Persians, one was Chinchilla and one was described as Angora. Twenty-nine cats were sterilised, 11 were non-sterilised and the status of 60 was unknown.
 
Isolation and identification
 
The urine samples were brought to the Routine Diagnostic Laboratory of the Microbiology Department of Istanbul University-Cerrahpaşa Faculty of Veterinary Medicine under a cold chain and were examined immediately without waiting. 100 μl of the samples were plated on 5% sheep Blood Agar and incubated under microaerobic conditions (7% CO2 added to the culture conditions) at 37°C for 24 hours. Catalase-negative, oxidase-negative Gram-positive cocci were considered suspect Enterococcus spp. Isolates were then plated on Enterococcosel Agar and the black colonies were considered Enterococcus spp. Isolates were stored at -80°C in Tryptic Soy Broth containing 50% glycerol until use (Arda, 2011).
 
DNA extraction
 
DNA was extracted from fresh cultures grown on blood agar using a 2% Chelex-100 solution (Tumpa et al., 2022).
 
Amplification
 
Multiplex polymerase chain reaction was used to identify Enterococcus spp isolates with Enterococcus faecium and Enterococcus faecalis-specific gene regions, according to the method reported by Tumpa et al., (2022).
 
Electrophoretic separation and detection of DNA
 
The PCR products obtained at the end of the cycles were electrophoresed in an agarose gel (1%). Electrophoresis was continued at 100 volts for 60 min. Isolates forming a 550bp band were identified as E. faecium and isolates forming a 941bp band were identified as E. faecalis. Samples that did not form bands were considered to be Enterococcus spp.
 
Antimicrobial susceptibility testing
 
According to the recommendations of the Clinical and Laboratory Standards Institute (CLSI, 2018), antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method on Mueller-Hinton agar (MHA). The antibiotic susceptibilities of the isolates were evaluated against amoxicillin/clavulanic acid (30 μg), penicillin (10 U), ampicillin (10 μg), ampicillin/sulbactam (20 μg), vancomycin (30 μg), cephalothin (30 μg), enrofloxacin (5 μg), marbofloxacin (5 μg), ciprofloxacin (5 μg), gentamicin (10 μg), erythromycin (15 μg), clindamycin (5 μg), oxytetracycline (30 μg) and sulfamethoxazole/trimethoprim (25 μg). Isolates resistant to three or more antibiotic classes were considered to have multidrug resistance (MDR) (Magiorakos et al., 2011).
 
Statistical analysis
 
The results were analysed with the SPSS 13.0 programme. The Chi-squared test was used for the comparisons of sex, age, breed and sterility status groups with respect to bacterial growth. Differences were considered significant at p<0.05.
UTIs in cats are relatively rare events due to various host defence mechanisms. Cats with bacterial UTIs have been reported to have anatomical, metabolic, or functional problems in the bladder or urethra or to have undergone urinary tract instrumentation (e.g., urinary catheterisation) that facilitates bacterial shedding and colonisation of the urinary tract (Chew et al., 2014). In this study, we aimed to determine the rate of bacterial UTI and the antimicrobial resistance profiles of enterococcal species isolated from samples in cats with urinary tract problems brought to the IU-C Veterinary Faculty Animal Hospital or private clinics around Istanbul between April and August (2023).
 
Isolation and identification
 
In 43 out of 100 urine samples, growth was observed plated on blood agar. A single organism was isolated in 38 of these, two in 4 patients and all three in one patient. It was found that 23 of the 49 organisms were Gram-positive cocci. After catalase and oxidase testing, ten isolates were found to be catalase and oxidase negative and were identified as suspected Enterococcus spp. Eight of the ten isolates that formed black colonies on Enterococcosel agar were identified as Enterococcus spp.
       
Eight isolates identified as Enterococcus spp. were tested by PCR using E. faecium and E. faecalis-specific primers. Six isolates were interpreted as E. faecalis and one as E. faecium. In contrast, one isolate that did not form a band was determined to be Enterococcus spp. As a result, E. faecalis was identified in five urine samples from seven cats, E. faecalis and E. faecium in one and Enterococcus spp. in one. In this study, no significant difference was found between sex, age, breed and sterility status groups with respect to bacterial growth statistically (p>0.05). The distribution and rates of enterococci isolated from cats with bacteriuria according to sex, age, breed and sterility status are shown in Table 1.
 

Table 1: Distribution of cats from which enterococci were isolated according to sex, age, breed and sterility status.


       
Although studies in previous years have reported that bacterial UTI in cats is not common, it has recently been reported that the prevalence has increased from 1% to 38% (Amphaiphan, 2021). Eggertsdottir et al., (2011) collected urine by cystocentesis from 108 healthy cats in Norway. They found that only 1% had bacterial growth and reported that contamination was sporadic when urine was collected by cystocentesis. D’Aout et al., (2022), in England, examined 2712 urine samples and found that 425 (15.7%) were culture-positive. Fonseca et al., (2021) detected bacteriuria in 10% of feline urine samples. Aurich et al., (2022) reported that uropathogenic bacterial growth was observed in 38.5% of cats in Germany and attributed the high prevalence to the higher number of female cats. Tumpa et al., (2022) showed bacteriological growth at 36% in Croatia and Amphaiphan et al., (2021) at 38% in Thailand. In this study, bacteriological growth was observed in 43 (43%) of the urine samples taken by cystocentesis from 100 cats. This bacteriological prevalence is much higher than the recent reports in Istanbul (Dokuzeylül, 2015, 2019).  Although Eggertsdottir et al., (2011) attributed the low prevalence to the fact that the samples were taken by cytosynthesis, in this study all samples were taken by cytosynthesis too. It is known that all of the cats sampled in this study were brought to clinics with various urinary tract problems. Similar high prevalence rates exist due to urinary tract defense mechanisms, effects of other diseases and/or treatment (e.g. catheterization, perineal urethrostomy) as reported in many studies and supports the work done in recent years. Since there are no specific clinical signs of UTI, the high prevalence found in this study shows the importance of bacteriological culture in animals with urinary tract problems.
       
The majority of UTIs are caused by bacteria, with bacteriuria usually resulting from pathogens in the host’s own enteric or distal urogenital flora. The majority (>85%) of UTIs are caused by a single bacterial pathogen (Dorsch et al., 2019). In both dogs and cats, Escherichia coli is the most commonly isolated pathogen from the urinary tract (Dorsch et al., 2019; Hernando et al., 2021; Thompson et al., 2011). The second most common isolate was found to be Enterococcus species, with detection rates ranging from 5% to 55% (Seidel et al., 2022). In a study conducted in Norway in 2015 by Lund et al., (2015), 82 bacteria were isolated from the urine of 71 cats and Enterococcus was found to be the third most frequently isolated bacterial species. In a 5-year retrospective study in Germany, Teichmann-Knorrn et al., (2018) isolated enterococci in 15.2% of cat urine and stated that they were the 3rd most frequently isolated bacteria. In the study by Aurich et al., (2022), also conducted in Germany, the most frequently isolated bacteria were Enterococcus spp., with 11.9%. In a study conducted in England in the same year, enterococci were found in cat urine at a similar rate (14.9%) (D’Aout et al., 2022). Another study conducted in England mentioned the prevalence of Enterococcus species by reporting that the second most common organism isolated from feline urine was Enterococcus species and that Enterococcus spp. was isolated from 40 of 171 cats (23.2%) (Fonseca et al., 2021). Similar to the high prevalence in England, Enterococcus spp. was isolated from 22.2% of feline urine in the Spanish study. It was found to be the second most commonly isolated bacterium after E. coli (Hernando et al., 2021). As in Europe, Enterococcus has been identified as the 2nd most frequently isolated pathogen from cat urine in Far Eastern countries such as Korea (Moon et al., 2022) and Taiwan (Lien and Wang, 2020). As a result of a retrospective study conducted in America, they showed that enterococci, with its ability to cause disease in healthy young or middle-aged cats, is not only an opportunistic organism but also a true uropathogen (Kukanich and Lubbers, 2015). In studies conducted in our country, Dokuzeylül et al., (2015) reported that bacterial growth was observed in 26.2% of urine samples from 61 cats with lower urinary tract infection (LUTI). They noted that the most commonly isolated agents were E. coli and Enterococcus sp. Again, in their 2019 study, Dokuzeylül et al., (2019) examined urine samples from 123 cats and detected bacterial growth in 28 (22.8%). They reported the isolation of Enterococcus faecalis as the third pathogen, after Staphylococcus sp. and E. coli. In this study, as reported by Dokuzeylül et al., (2019), Enterococcus was detected as the third most frequently isolated agent after Staphylococcus sp. and E. coli. 18.6% of the isolates were identified as enterococci and this rate was compatible with the prevalence of studies conducted in other countries.
       
When looking at the distribution of enterococci species in cat urine, the most frequently isolated species has been reported to be E. faecalis (Litster et al., 2009; Marques et al., 2018; Moyaert et al., 2017). Kukanich and Lubbers (2015) identified all enterococci isolated from urine samples collected from cats by cystocentesis or with a sterile catheter as E. faecalis. Aurich et al., (2022) found that 71.8% of the enterococci they isolated were E. faecalis, 7.6% were E. faecium and 20.5% were other Enterococci species. However, some studies have found E. faecium to be the dominant species among enterococci isolated from urine. Lien and Wang (2020) found that of the 11 (14.9%) enterococcal isolates isolated from cat urine, seven were E. faecium and three were E. faecalis and they identified one as E. gallinarum. Similarly, Tumpa et al., (2022) identified six of the seven enterococcal isolates they isolated as E. faecium and one as E. faecalis. In this study, consistent with the findings of Litster et al., (2009), Marques et al., (2018), Moyaert et al., (2017) and Aurich et al., (2022), the highest proportion of cat urine samples were isolated and identified as E. faecalis (75%), followed by E. faecium (12.5%). In total, six of the eight enterococci isolated were identified as E. faecalis, one as E. faecium and one as Enterococcus spp.
 
Determination of antibiotic susceptibility of isolates
 
As a result of the antibiotic susceptibility tests, the highest resistance was found against cephalothin (100%) and penicillin, erythromycin, clindamycin and oxytetracycline (87.5%). While no vancomycin resistance was observed in any isolate, enrofloxacin and ciprofloxacin had the lowest resistance (33.3%). Resistance to three or more antibiotic classes was detected in all isolates (100%) and all isolates were classified as MDR. Antibiotic resistance prevalence of isolates and Antibiotic resistance profiles of isolates are shown in Table 2 and Table 3, respectively.
 

Table 2: Antibiotic resistance prevalence of isolates.


 

Table 3: Antibiotic resistance profiles of isolates.


       
Enterococci are naturally resistant to several commonly used antimicrobial drugs. They also have a great capacity to acquire new resistance mechanisms that can lead to multidrug-resistant isolates that can be partially treated with currently known antimicrobial agents (Kataoka et al., 2014; Marques et al., 2018; Scarborough et al., 2020). In their study, Tumpa et al., (2022) reported that most enterococcal isolates were resistant to major classes of antibiotics and 80% were multidrug-resistant (MDR). They also noted that despite the high level of antibiotic resistance, no aminoglycoside resistance was found and that the one E. faecium isolate was susceptible to all antibiotics tested. A German study found that while 58% of enterococci isolates were MDR, most were susceptible to beta-lactam antibiotics, enrofloxacin, amoxicillin and amoxicillin-clavulanic acid. Researchers attributed the high MDR found to the fact that almost half of the animals sampled in the study had received antimicrobial treatment before sampling. They may have developed resistance to antimicrobials (Aurich et al., 2022). In this study, antimicrobial susceptibility testing was performed with 14 antibiotics from eight different antimicrobial classes. The antimicrobials were selected primarily on the basis of those commonly used in veterinary medicine to treat human enterococcal infections. Consistent with the studies by Smoglica et al., (2022) and Amphaiphan et al., (2021), this study found 100% multidrug resistance in Enterococcus species isolated from the urinary tract. This indicates that the potential for transmission of multidrug-resistant organisms from companion animals may be increasing and is a public health concern.
       
The antimicrobial working group of the International Society for Companion Infectious Diseases (ISCAID) has recommended amoxicillin (or amoxicillin/clavulanic acid) or trimethoprim-sulphonamides as first-line treatment for bacterial UTI in cats (Weese et al., 2019). Although recent studies have reported decreased susceptibility to amoxicillin, it is still one of the first-line drugs recommended for the treatment of UTI. Half of the isolates in this study were resistant to amoxicillin/clavulanic acid. This may be due to geographical distribution and differences in antimicrobial use between countries, but the results are worrying. Trimethoprim-sulfamethoxazole resistance was found to be 75% in this study, similar to studies reporting resistance of 94.3% (D’Aout et al., 2022) and 100% Lien and Wang (2020). In the time since ISCAID recommendations, there has been an increase in the development of resistance to amoxicillin (or amoxicillin/clavulanic acid) and trimethoprim-sulphonamides. This highlights the need to regularly update antimicrobial resistance profiles worldwide to re-evaluate the treatment of antibiotics that have become resistant in the light of the results.
       
Intrinsic resistance to cephalosporins is expected in enterococci, making their use problematic. A study of antimicrobial prescriptions for cats diagnosed with urinary tract disease in the USA and Canada found that cefovecin was the most commonly prescribed antibiotic (61%). This inappropriate use is not only ineffective in treatment but may also lead to increased antimicrobial resistance (Weese et al., 2021). In this study, resistance to cephalothin, a cephalosporin group antibiotic, was tested and 100% resistance was observed.
       
Similar to EUCAST (2021), which states that ampicillin resistance is common in E. faecium but rare in E. faecalis, in this study, the only E. faecium isolate was resistant to ampicillin, while resistance in E. faecalis was 33.3%. Resistance to fluoroquinolones has been reported to range from 56 to 99% (Marques et al., 2018; Fonseca et al., 2021). While Tumpa et al., (2022) and Smoglica et al., (2022) reported high resistance to fluoroquinolones in general, Scarborough et al., (2020), Aurich et al., (2022) and Lien and Wang (2020) highlighted high resistance to enrofloxacin in particular. In this study, enrofloxacin and ciprofloxacin resistance was found to be low (37.5%), consistent with the findings of D’Aout et al., (2022) (40%). In studies of human urinary tract infections, ciprofloxacin resistance is relatively high (66-91%) (Tumpa et al., 2022). The low resistance found is encouraging, as fluoroquinolones are considered to be the most important antimicrobial class for humans. They are also of great importance for the treatment of companion animals. However, we should not forget that the use of this class of antibiotics needs to be controlled.
Since it is possible for resistant bacteria and resistance genes to be transmitted from animals to humans, the presence of multidrug-resistant enterococci in companion animals is a major threat to public health. Bacteriological culture and antimicrobial susceptibility testing should always be performed for UTIs to guide definitive diagnosis and antibiotic selection. Knowledge of the regional antimicrobial resistance status is also important for empiric antibiotic selection pending bacterial culture and antimicrobial susceptibility testing. The recent increase in resistance to antibiotics recommended for the treatment of enterococcal UTIs is of great concern. For this reason, epidemiological studies should be carried out at regular intervals in every country on cats that live with us in our homes, go to the toilet in our homes and use our beds. Bacterial UTI pathogens should be identified by bacteriological culture and then resistance profiles should be determined by antimicrobial susceptibility testing. It is, therefore, necessary to be informed about the evolving resistance status of antibiotics and to update antibiotic use protocols.
Study supported by Istanbul University-Cerrahpasa, Scientific Research Projects Coordination Unit. Project number: TYL-2023-37044.
 
Animal welfare and ethics
 
Permission was taken from the Animal Use and Care Committee at the Faculty of Veterinary Medicine, Istanbul University- Cerrahpaþa (Eth No: E-72796624-604.02.01-601977). 
All authors declare that they have no conflicts of interest.

  1. Amphaiphan, C., Yano, T., Som in, M., Kungwong, P., Wongsawan, K., Pusoonthornthum, R., Salman, M.D. and Tangtrongsup, S. (2021). Antimicrobial drug resistance profile of isolated bacteria in dogs and cats with urologic problems at Chiang Mai University Veterinary Teaching Hospital, Thailand (2012-2016). Zoonoses public heallth. 68(5): 452-463.

  2. Arda, M. (2011). Tıbbi Mikrobiyoloji. 4. baskı, Medisan Yayınevi, Ankara.

  3. Aurich, S., Prenger-Berninghoff, E. and Ewers, C. (2022). Prevalence and antimicrobial resistance of bacterial uropathogens isolated from dogs and cats. Antibiotics. 11(12): 1730.

  4. Banik, A., Isore, D. P., Joardar, S. N., Batabyal, K. and Dey, S. (2016). Characterization and antibiogram of enteropathogenic Escherichia coli isolated from diarrhoeic and non-diarrhoeic dogs in South Bengal. Indian J. Anim. Res. 50(5): 773- 775. doi: 10.18805/ijar.5713.

  5. Chew, D.J., Dibartola, S.P. and Schenck, P. (2014). Cystitis and urethritis: Urinary tract infection.

  6. Clinical and Laboratory Standards Institute (CLSI). (2018). VET01 A5: Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, approved standard. Wayne, PA.

  7. D’Août, C., Taylor, S.S., Gelendi, S., Atkinson, C. and Defauw, P. (2022). Bacteriuria in cystocentesis samples from cats in the United Kingdom: prevalence, bacterial isolates and antimicrobial susceptibilities. Animals. 12(23): 3384.

  8. Dokuzeylül, B., Celik, B., Siðirci, B.D., Kahraman, B.B., Saka, S.Ü., Kayar, A. and Or, M.E. (2019). Clinical efficacy of marbofloxacin in dogs and cats diagnosed with lower urinary tract disorders. Med. Weter. 75(9): 549-552.

  9. Dokuzeylül, B., Kahraman, B.B., Bayrakal, A., Siðirci, B.D., Çelik, B., Ikiz, S. and Or, M.E. (2015). Bacterial species isolated from cats with lower urinary tract infection and their susceptibilities to cefovecin. Ir. Vet. J. 68(1): 1-5.

  10. Dorsch, R., Teichmann-Knorrn, S. and Lund, H.S. (2019). Urinary tract infection and subclinical bacteriuria in cats: A clinical update. J. Feline Med. Surg. 21(11): 1023-1038.

  11. Dotto, G., Berlanda, M., Pasotto, D., Mondin, A., Zambotto, G. and Menandro, M.L. (2018). Pets as potential carriers of multidrug-resistant Enterococcus faecium of significance to public health. New Microbiol. 41(2): 168-172.

  12. Eggertsdóttir, A.V., Sćvik, B.K., Halvorsen, I. and Sørum, H. (2011). Occurrence of occult bacteriuria in healthy cats. J. Feline Med. Surg. 13(10): 800-803.

  13. Fonseca, J.D., Mavrides, D.E., Graham, P.A. and McHugh, T.D. (2021). Results of urinary bacterial cultures and antibiotic susceptibility testing of dogs and cats in the UK. J. Small Anim Pract. 62(12): 1085-1091.

  14. Hernando, E., Vila, A., Dippolito, P., Rico, A.J., Rodon, J. and Roura, X. (2021). Prevalence and characterisation of urinary tract infection in owned dogs and cats from Spain. Top. Companion Anim. Med. 43: 100512.

  15. Kataoka, Y., Umino, Y., Ochi, H., Harada, K. and Sawada, T. (2014). Antimicrobial susceptibility of enterococcal species isolated from antibiotic-treated dogs and cats. J. Vet. Med. Sci. 76(10): 1399-1402.

  16. Kýrkan, S., Parin, U. and Balat, G. (2019). Antimicrobial resistance of isolated from the urinary system of Dogs. Maced. Vet. Rev. 42(1): 15-21.

  17. Kukanich, K.S. and Lubbers, B.V. (2015). Review of enterococci isolated from canine and feline urine specimens from 2006 to 2011. J. Am. Anim. Hosp. Assoc. 51(3): 148-154.

  18. Lien, C.J. and Wang, S.L. (2020). Antimicrobial resistance of common uropathogens from cats with urinary tract infections in a veterinary teaching hospital in Taiwan. Taiwan Vet. J. 46(01): 21-28.

  19. Litster, A., Moss, S., Platell, J. and Trott, D.J. (2009). Occult bacterial lower urinary tract infections in cats urinalysis and culture findings. Vet. Microbiol. 136(1-2): 130-134.

  20. Lund, H.S., Skogtun, G., Sørum, H. and Eggertsdóttir, A.V. (2015). Antimicrobial susceptibility in bacterial isolates from Norwegian cats with lower urinary tract disease. J. Feline Med. Surg. 17(6): 507-515.

  21. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G. and Monnet, D.L. (2011). Multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-1 resistant (PDR) bacteria in healthcare settings. Expert proposal for a 2 standardised international terminology. 3.

  22. Marques, C., Belas, A., Franco, A., Aboim, C., Gama, L.T. and Pomba, C. (2018). Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16- year retrospective study. J Antimicrob Chemother. 73(2): 377-384.

  23. Mayer-Roenne, B., Goldstein, R. E. and Erb, H.N. (2007). Urinary tract infections in cats with hyperthyroidism, diabetes mellitus and chronic kidney disease. J. Feline Med. Surg. 9(2): 124-132.

  24. Moon, D.C., Choi, J.H., Boby, N., Kim, S.J., Song, H.J., Park, H.S. and Lim, S.K. (2022). Prevalence of bacterial species in cats. Pathogens. 11(3): 324.

  25. Moyaert, H., Morrissey, I., de Jong, A., El Garch, F., Klein, U., Ludwig, C. and Youala, M. (2017). Antimicrobial susceptibility monitoring of bacterial pathogens isolated from urinary tract infections in dogs and cats across Europe: ComPath results. Microb Drug Resist. 23(3): 391-403.

  26. Parmar, J.J., Parikh, P.V., Shah, A.I. and Dabhi, P.B. (2021a). Retrospective analysis of lower urinary tract disorders in dogs: Study of five years. Indian J. Anim. Res. 55(8): 941-945. doi: 10.18805/ijar.B-4146.

  27. Parmar, J.J., Parikh, P.V., Panchal, M.T., Ghodasara, D.J. and Bhanderi, B.B. (2021b). Clinico-diagnosis and surgico- therapeutic management of lower urinary tract disorders in dogs. Indian J. Anim. Res. 55(11): 1315-1322. doi: 10.18805/IJAR.B-4239.

  28. Sævik, B.K., Trangerud, C., Ottesen, N., Sørum, H. and Eggertsdóttir, A.V. (2011). Causes of lower urinary tract disease in Norwegian cats. J. Feline Med. Surg. 13(6): 410-417.

  29. Scarborough, R., Bailey, K., Galgut, B., Williamson, A., Hardefeldt, L., Gilkerson, J. and Browning, G. (2020). Use of local antibiogram data and antimicrobial importance ratings to select optimal empirical therapies for urinary tract infections in dogs and cats. Antibiotics. 9(12): 924.

  30. Seidel, E.J., Hess, R.S., Cole, S.J. and McClosky, M.E. (2022). Clinical differences in enterococcal bacteriuria compared with other bacteriuria in cats. J. Feline Med. Surg. 24(12): e546-e550.

  31. Smoglica, C., Evangelisti, G., Fani, C., Marsilio, F., Trotta, M., Messina, F. and Di Francesco, C.E. (2022). Antimicrobial resistance profile of bacterial isolates from urinary tract infections in companion animals in Central Italy. Antibiotics. 11(10): 1363.

  32. Teichmann Knorrn, S., Reese, S., Wolf, G., Hartmann, K. and Dorsch, R. (2018). Prevalence of feline urinary tract pathogens and antimicrobial resistance over five years. Vet Rec. 183(1): 21-21.

  33. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). (2021). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 11.0. Available online: http://www.eucast.org (accessed on 1 september 2023).

  34. Thompson, M.F., Litster, A.L., Platell, J.L. and Trott, D.J. (2011). Canine bacterial urinary tract infections: New developments in old pathogens. Vet J. 190(1): 22-27.

  35. Tumpa, A., Štritof, Z. and Pintariæ, S. (2022). Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in north-western Croatia. Res. J. Vet. 151: 42-46.

  36. Weese, J.S., Blondeau, J., Boothe, D., Guardabassi, L.G., Gumleyg, N., Papichh, M. and Sykes, J. (2021). International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. J. Japanese Ass. Vet. Nephrol. Urol. 13(1): 46-63.

  37. Weese, J.S., Blondeau, J. and Boothe, D. (2019). International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. Vet. J. 247: 8-25.

Editorial Board

View all (0)